Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_assertion type Assertion NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_head.
- NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_assertion wasGeneratedBy ECO_0000203 NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_provenance.
- NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_assertion wasDerivedFrom befree-2016 NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_provenance.
- NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_assertion SIO_000772 24561032 NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_provenance.
- NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_assertion evidence source_evidence_literature NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_provenance.
- NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_assertion description "[We investigated the anti-tumor activity of the PI3K inhibitor NVP BKM-120 (BKM) as a single agent and in combination with standard cytotoxic chemotherapy in a human primary endometrial xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157386.RA1tudEJJCbynYEfAx_e8D8O9KqkohR7KRh9t0YrB7ps8130_provenance.